Biotech

All Articles

Amgen documents first stage 3 win for $400M dermatitis drug

.Amgen has actually shared (PDF) the first phase 3 records on its own $400 million dermatitis drug, ...

Biogen, UCB file stage 3 lupus win after stopping working earlier trial

.Biogen as well as UCB's rely on advancing into stage 3 on the back of a broken study looks to have ...

Aptadir really hopes brand new RNA preventions can turn around difficult cancers

.Italian biotech Aptadir Therapeutics has actually released with the pledge that its own pipeline of...

Wave surfs DMD results to regulators' doors, sending out stock up

.Surge Lifestyle Sciences has actually satisfied its objective in a Duchenne muscular dystrophy (DMD...

Sanofi plucks brand new CSO from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is actually going back to the pharma layer...

Achilles drops cell treatment program, prepares for cutbacks after missing out on 'office feasibility' targets

.Achilles Therapeutics has destroyed its own method. The British biotech is knocking off on its clin...

Aligos advertises stage 2 MASH gain, slashing liver body fat up to 46%

.Aligos Rehabs is trumpeting a midstage gain in metabolic-dysfunction linked steatohepatitis (MASH) ...

Basilea ratings $268M BARDA financing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work creating brand-new antifungals has obtained a significant improvement ...

Capricor sells Europe legal rights to late-stage DMD therapy for $35M

.Having currently gathered up the united state rights to Capricor Therapies' late-stage Duchenne mus...

FDA junks adcomm for Applied's uncommon condition medication

.After dismissing the selection date for Applied Therapies' metabolic disorder drug govorestat, the ...